Jie Lin

发表

Overview of the current status of familial hypercholesterolaemia care in over 60 countries - The EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC).

J. Car, H. Schunkert, S. Yamashita, 2018, Atherosclerosis.

Comparative aspects of the care of familial hypercholesterolemia in the "Ten Countries Study".

S. Yamashita, Z. Ademi, G. Watts, 2019, Journal of clinical lipidology.

Health literacy in familial hypercholesterolemia: A cross-national study

G. Watts, M. Hagger, R. Santos, 2018, European journal of preventive cardiology.

A cross-national investigation of cardiovascular survival in homozygous familial hypercholesterolemia: The Sino-Roman Study.

G. Watts, J. Pang, C. Stefanutti, 2019, Journal of clinical lipidology.

A PCSK9 inhibitor induces a transient decrease in the neutrophil-lymphocyte ratio and monocyte-lymphocyte ratio in homozygous familial hypercholesterolemia patients

Y. Hao, Jie Lin, Juan Du, 2022, Atherosclerosis plus.

Pooling and expanding registries of familial hypercholesterolaemia to assess gaps in care and improve disease management and outcomes: Rationale and design of the global EAS Familial Hypercholesterolaemia Studies Collaboration.

J. Car, H. Schunkert, S. Yamashita, 2016, Atherosclerosis. Supplements.

Percutaneous coronary intervention for a Chinese familial hypercholesterolemia homozygous under the guidance of optical coherence tomography.

Jie Lin, Yan Chen, K. Meng, 2019, Atherosclerosis. Supplements.

Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC)

G. Francis, Qian Wang, D. Gaudet, 2021, The Lancet.

Familial hypercholesterolemia in China half a century: A review of published literature.

Jing Hong, Jie Lin, Xue Wu, 2019, Atherosclerosis. Supplements.

region : the ' ' Ten Countries Study ' ' primary care physicians in the Asia-Pacific familial hypercholesterolaemia among and preferences concerning the care of questionnaire into knowledge , awareness An enquiry based on a standardised

S. Yamashita, G. Watts, A. Ramli, 2017 .

An enquiry based on a standardised questionnaire into knowledge, awareness and preferences concerning the care of familial hypercholesterolaemia among primary care physicians in the Asia-Pacific region: the “Ten Countries Study”

S. Yamashita, G. Watts, A. Ramli, 2017, BMJ Open.

Translational Research for Improving the Care of Familial Hypercholesterolemia: The "Ten Countries Study" and Beyond.

S. Yamashita, G. Watts, M. Hagger, 2016, Journal of atherosclerosis and thrombosis.

Familial hypercholesterolemia in China: prevalence and evidence of underdetection and undertreatment in a community population.

G. Watts, Anne W. Taylor, Zumin Shi, 2014, International journal of cardiology.

Functional analysis of low‐density lipoprotein receptor in homozygous familial hypercholesterolemia patients with novel 1439 C→T mutation of low‐density lipoprotein receptor gene

Shu Liu, Zhi-Sheng Jiang, Luya Wang, 2008, Chinese medical journal.

Noninvasive Evaluation of Coronary Flow Velocity Reserve in Homozygous Familial Hypercholesterolemia by Transthoracic Doppler Echocardiography

Zhi-an Li, Ya Yang, Jie Lin, 2010, Echocardiography.

Evaluation of coronary flow velocity reserve in homozygous familial hypercholesterolemia by transthoracic Doppler echocardiography and dual-source computed tomography.

Zhao-qi Zhang, Wei Yu, Z. Wang, 2010, Ultrasound in medicine & biology.

[Methylation and expression of gene p16INK4a and RB in gastric carcinomas].

Jie Lin, Songnian Liu, Juan Du, 2003, Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences.

A novel mutation in proprotein convertase subtilisin/kexin type 9 gene leads to familial hypercholesterolemia in a Chinese family.

Shu Liu, Zhi-Sheng Jiang, Luya Wang, 2010, Chinese medical journal.

Seven-year clinical follow-up of a Chinese homozygous familial hypercholesterolemia child with premature xanthomas and coronary artery disease--a need for early diagnosis and aggressive treatment.

F. Gao, Q. Wang, Long Jiang, 2014, International journal of cardiology.

Corneal arcus and xanthomas in homozygous familial hypercholesterolemia: First report from China

Jie Lin, Jun Wang, Jia Guo, 2013, Indian journal of ophthalmology.

A novel mutation of the LDL receptor gene leading to familial hypercholesterolemia

Ying-Jia Xu, Zhao-su Wu, Luya Wang, 2009 .

PCSK9 Inhibitor Induces a Transient Decrease in Neutrophil-Lymphocyte Ratio and Monocyte-Lymphocyte Ratio in Homozygous/Compound Heterozygous Familial Hypercholesterolemia Patients

Y. Hao, Jie Lin, Juan Du, 2021 .

Characterization of coronary atherosclerotic plaques in a homozygous familial hypercholesterolemia visualized by optical coherence tomography

Jie Lin, K. Meng, Zesen Liu, 2018, Journal of geriatric cardiology : JGC.

Reverse cascade screening for familial hypercholesterolemia in high‐risk Chinese families

G. Watts, J. Pang, Jie Lin, 2017, Clinical cardiology.

Predicting intention to participate in self-management behaviors in patients with Familial Hypercholesterolemia: A cross-national study.

G. Watts, M. Hagger, R. Santos, 2019, Social science & medicine.

Analysis of low-density lipoprotein receptor gene mutations in a Chinese patient with clinically homozygous familial hypercholesterolemia.

Shu Liu, Luya Wang, Bao-sheng Chen, 2003, Chinese medical journal.

Effects of medication, treatment, and behavioral beliefs on intentions to take medication in patients with familial hypercholesterolemia.

G. Watts, M. Hagger, R. Santos, 2018, Atherosclerosis.

RUNNING HEAD: Treatment Beliefs and Intention to Take Medication in FH 1 FH Special issue-Effects of Medication, Treatment, and Behavioral Beliefs on Intentions to Take Medication in Patients with Familial Hypercholesterolemia

M. Hagger, R. Santos, S. Hardcastle, 2018 .

R306S gain-of-function mutation enhances PCSK9-mediated lowering of LDL-R expression

Jie Lin, Zuo Wang, Xiaodong Pan, 2011, 2011 4th International Conference on Biomedical Engineering and Informatics (BMEI).

Genome-Wide Linkage Scan of a Pedigree with Familial Hypercholesterolemia Suggests Susceptibility Loci on Chromosomes 3q25-26 and 21q22

Duen-mei Wang, Yong-biao Zhang, Xin Li, 2011, PloS one.

The serum anion gap is associated with disease severity and all-cause mortality in coronary artery disease

Jie Du, Yu-jie Zhou, Yu-yang Liu, 2017, Journal of geriatric cardiology : JGC.

Effectiveness of reverse cascade screening for familial hypercholesteroleamia in very high risk families in China.

G. Watts, J. Pang, Jing Hong, 2017, Atherosclerosis.

S. Yamashita, G. Watts, A. Ramli, 2017, BMJ Open.

Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC).

G. Francis, Qian Wang, D. Gaudet, 2021, Lancet.